Navigation Links
Successful ILM-Blue Patent Opposition Proceedings Before the European Patent Office; Patent Validity Confirmed
Date:12/14/2011

Belgium, United Kingdom, Austria and The Netherlands. The DORC companies employ about 300 people.

Visit our website : http://www.dorc.nl

 



'/>"/>
SOURCE Dutch Ophthalmic Research Center International BV
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
3. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
4. New Study Proves That Minimally Invasive Aneurysm Treatment Yields Successful Long-Term Results
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
7. EpiCept Announces Successful Completion of Enrollment for Phase I Trial of EPC2407
8. Researchers Report First Successful Treatment of Chronic Traumatic Brain Injury
9. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
10. PLC Systems Achieves Successful Early Conclusion of RenalGuard(TM) Pilot Safety Trial
11. YMed, Inc. Successfully Completes First Clinical Cases With Innovative VascuTraK(TM) II PTA Dilatation Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... 1, 2014   Plexus Information Systems, Inc. ... Information Management Systems (AIMS), announced a partnership with ... wholly owned subsidiary of Quality Systems, Inc. and ... connectivity solutions.  Logo - ... This partnership extends the NextGen Healthcare ...
(Date:10/1/2014)... NOTTINGHAM, England , Oct. 1, 2014  Columbia ... that its subsidiary, Molecular Profiles Ltd., is set to ... annual CPhI/ICSE Worldwide event in Paris ... the rapid development of both standard and complex drug ... which incorporates the company,s existing formulation and analytical development ...
(Date:10/1/2014)... ANTWERP, Belgium and NEW YORK , ... global Contract Research Organization (CRO) and service provider for the medical ... the opening of offices in New York City ... New York City is strategically centered in one of ... the East Coast", said Philippe Kassab , President at genae ...
Breaking Medicine Technology:Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 2Plexus IS' Anesthesia Documentation Solution Strengthens NextGen Healthcare Product Offering 3Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 2Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 3genae Opens Offices in New York City 2
... Published in The Lancet of Fast-Tracked Antiplatelet Agent Showed ... was Well Tolerated When Given With Standard Platelet TherapyKENILWORTH, ... (NYSE: SGP ) Phase II trial of ... were published today in The Lancet and ...
... uses quantitative imaging endpoints from MRI analysesROCHESTER, N.Y., ... VSCP ), a leading provider of quantitative imaging ... a Canadian medical device company based in Laval, ... Canadian-European pivotal clinical trial for its cartilage repair ...
Cached Medicine Technology:Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 2Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 3Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 4Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 5Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 6Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study 7VirtualScopics' Quantitative Imaging Provides Primary Endpoint in Cartilage Repair Pivotal Clinical Trial 2VirtualScopics' Quantitative Imaging Provides Primary Endpoint in Cartilage Repair Pivotal Clinical Trial 3
(Date:10/2/2014)... BamboofloorChina.com is a distinguished bamboo product manufacturer and retailer. ... the global customers in the past few years. Now, ... items. All its online workers are professional and patient; ... The company has recently added a new assortment of ... company’s marketing specialist has announced that all these brand ...
(Date:10/2/2014)... (HealthDay News) -- Children with autism are more sedentary ... of being more active, a small study suggests. ... children, some with autism and some without. Children with ... physical activity and 70 more minutes each day sitting ... autism scored lower on strength, but had similar body-mass ...
(Date:10/2/2014)... By Dennis Thompson ... -- Forty-two states and the District of Columbia now have ... severe respiratory illness that has been infecting children since ... infected with the virus have died in recent weeks, but ... virus played in those deaths, officials said. Health officials ...
(Date:10/1/2014)... A new research study published today in the ... in patients older than 50 years with moderate or ... benefit. , Researchers from the University of Melbourne randomly ... knee pain to no acupuncture or sham or pretend ... weeks with participants and acupuncturists blinded to laser and ...
(Date:10/1/2014)... people to keep their "eyes on the prize" may ... walking, staying focused on a specific target ahead can ... people walk there faster, psychology researchers have found. Their ... around the environment naturally, offers a new strategy to ... interested in exercise if physical activity seems daunting, which ...
Breaking Medicine News(10 mins):Health News:High Quality Bamboo Panels Online At BamboofloorChina.com 2Health News:Kids With Autism Tend to Be Less Active, Study Says 2Health News:42 States Reporting Respiratory Virus That Targets Kids 2Health News:42 States Reporting Respiratory Virus That Targets Kids 3Health News:Study finds acupuncture does not improve chronic knee pain 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 3
... 1 /PRNewswire-Asia/ -- Linkwell Corporation,(OTC Bulletin Board: LWLL), a ... put forward its worries about,the trend of the misunderstanding ... "Antisepsis is one of the most ... will work best when used with the H1N1 vaccine,",said ...
... , GENEVA, Sept. 1 Selexis SA ... they have entered into a research services agreement whereby ... CHO-based production cell lines using their novel platform named ... of production cell lines concomitant with the selection of ...
... in half for Italian study patients , TUESDAY, Sept.1 (HealthDay ... to develop blood clots than other people, but now a ... in half. , Besides posing a significant risk of ... especially difficult to treat in cancer patients and can lead ...
... , , , ... leaders, health plan executives and experts from Health Integrated will share perspectives ... during a provocative two-day program at The Westin Michigan Avenue in Chicago, ... http://www.newscom.com/cgi-bin/prnh/20090709/FL43703LOGO ) , , "Wins of ...
... , , COLUMBUS, Ga., ... for Childhood Cancer Awareness Month by kicking off a new integrated fundraising ... Service of Children,s Healthcare of Atlanta . Childhood cancer is the ... of 15. Through improved research and treatments, childhood cancer survival rates have ...
... KENILWORTH, N.J., Sept. 1 Schering-Plough Corporation (NYSE: ... only 12-hour allergy medicine found in the allergy aisle. New CLARITIN ... worst indoor and outdoor allergy symptoms. The product is available ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20090901/NY68186 ) , ...
Cached Medicine News:Health News:Which is the Real Terminator of H1N1 Disease, the Antisepsis or the Vaccine? 2Health News:Which is the Real Terminator of H1N1 Disease, the Antisepsis or the Vaccine? 3Health News:Selexis and NKT Therapeutics Enter Into Research Services Agreement 2Health News:Blood Thinner May Prevent Chemo-Related Clots 2Health News:Health Plan Executives to Share Winning Strategies in the Age of Reform During Health Integrated Forum 2Health News:Aflac Announces Support for Childhood Cancer Awareness Month 2Health News:Aflac Announces Support for Childhood Cancer Awareness Month 3Health News:Aflac Announces Support for Childhood Cancer Awareness Month 4Health News:Aflac Announces Support for Childhood Cancer Awareness Month 5Health News:New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day 2Health News:New Non-Drowsy CLARITIN(R) 12-Hour Gets Allergy Sufferers Through Their Busy Day 3
... the first skull pin to utilize cutting edges instead ... its way into bone the Hifix pin drills a ... improved initial fixation over standard skull pins. The Hifix ... Hifix pins and in the bremer 3D halo crown. ...
It is designed for rigid skeletal fixation. These pins are constructed of stainless steel and can be removed for sterilization and reuse....
Endoscopes...
Patented* Design for Endoscopic Shunt Placement. Designed to pass through standard shunt ventricular catheters for optically guided placement....
Medicine Products: